By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies announced after the close of the market on Wednesday that it has made an equity investment in Synthetic Genomics, the firm behind research by Craig Venter and colleagues that resulted in the first functional bacterial cells controlled by a synthetic genome.

Terms of the investment were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.